Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 1374-1379, April 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, T.
Right arrow Articles by Kuwahara, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, T.
Right arrow Articles by Kuwahara, K.

Lethal Effect of Bleomycin and Peplomycin on HeLa Cells in Multicell Tumor Spheroids1

Takehito Sasaki2, Masahiko Yamamoto and Kenji Kuwahara

Departments of Radiation Research [T. S., M. Y.] and Neurosurgery [K. K.], Tohoku University School of Medicine, Seiryo-cho 2-1, Sendal 980, Japan

The lethal effects of bleomycin and its derivative, peplomycin, were determined for HeLa S3 cells grown in multicell spheroids cocultured with human diploid fibroblasts. Both drugs were less effective for cells in spheroids than for cells grown exponentially in monolayers. However, HeLa cells from spheroids exposed to the drugs in single-cell suspension were more sensitive to the drugs than were cells in monolayers. Sequential trypsinization of spheroids after exposure to both drugs showed that the surviving fraction increased sharply with increasing depth of cell layers in the spheroids. The presence of 0.5 mM misonidazole, a hypoxic radiosensitizer, enhanced the lethal effect of peplomycin only for the cells in the deeper layer. These findings suggest that the drug resistance of cells in spheroids was due, at least in part, to the microenvironment of the deeper layers. When spheroids were incubated in fresh medium following exposure to both drugs, the cells recovered from the potentially lethal damage within 1 hr. The extent of the recovery from a fixed drug concentration was higher in cells of the superficial layers than in cells of the deeper layers. It is suggested that the limitation of the lethal effects of bleomycin and peplomycin in solid tumors may be overcome by improving the state of oxygenation of hypoxic cells and by combining either drug with one which inhibits recovery from potentially lethal damage.

1 This investigation was supported by Grant-in-Aid for Cancer Research 57010008 from the Ministry of Education, Science and Culture, Japan.

2 To whom requests for reprints should be addressed, at the Department of Radiation Research, Tohoku University School of Medicine, Seiryo-cho 2-1, Sendai 980, Japan.

Received 2/10/83. Accepted 12/21/83.




This article has been cited by other articles:


Home page
Arch Otolaryngol Head Neck SurgHome page
N. Kohno, T. Ohnuma, H. F. Biller, and J. F. Holland
Effects of Cisplatin Plus Fluorouracil vs Cisplatin Plus Cytarabine on Head and Neck Squamous Multicellular Tumor Spheroids
Arch Otolaryngol Head Neck Surg, February 1, 1988; 114(2): 157 - 161.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.